Back to Search
Start Over
WAO-ARIA consensus on chronic cough – Part III
- Source :
- World Allergy Organization Journal, World Allergy Organization Journal, 2022, 15 (5), pp.100649. ⟨10.1016/j.waojou.2022.100649⟩
- Publication Year :
- 2022
-
Abstract
- BACKGROUND: Chronic cough management necessitates a clear integrated care pathway approach. Primary care physicians initially encounter the majority of chronic cough patients, yet their role in proper management can prove challenging due to limited access to advanced diagnostic testing. A multidisciplinary approach involving otolaryngologists and chest physicians, allergists, and gastroenterologists, among others, is central to the optimal diagnosis and treatment of conditions which underly or worsen cough. These include infectious and inflammatory, upper and lower airway pathologies, or gastro-esophageal reflux. Despite the wide armamentarium of ancillary testing conducted in cough multidisciplinary care, such management can improve cough but seldom resolves it completely. This can be due partly to the limited data on the role of tests (eg, spirometry, exhaled nitric oxide), as well as classical pharmacotherapy conducted in multidisciplinary specialties for chronic cough. Other important factors include presence of multiple concomitant cough trigger mechanisms and the central neuronal complexity of chronic cough. Subsequent management conducted by cough specialists aims at control of cough refractory to prior interventions and includes cough-specific behavioral counseling and pharmacotherapy with neuromodulators, among others. Preliminary data on the role of neuromodulators in a proof-of-concept manner are encouraging but lack strong evidence on efficacy and safety. OBJECTIVES: The World Allergy Organization (WAO)/Allergic Rhinitis and its Impact on Asthma (ARIA) Joint Committee on Chronic Cough reviewed the recent literature on management of chronic cough in primary, multidisciplinary, and cough-specialty care. Knowledge gaps in diagnostic testing, classical and neuromodulator pharmacotherapy, in addition to behavioral therapy of chronic cough were also analyzed. OUTCOMES: This third part of the WAO/ARIA consensus on chronic cough suggests a management algorithm of chronic cough in an integrated care pathway approach. Insights into the inherent limitations of multidisciplinary cough diagnostic testing, efficacy and safety of currently available antitussive pharmacotherapy, or the recently recognized behavioral therapy, can significantly improve the standards of care in patients with chronic cough. ispartof: WORLD ALLERGY ORGANIZATION JOURNAL vol:15 issue:5 ispartof: location:United States status: published
- Subjects :
- EXHALED NITRIC-OXIDE
Pulmonary and Respiratory Medicine
Cough specialty care
Chronic cough management
Allergy
AIRWAY INFLAMMATION
Upper airway cough syndrome
Immunology
MUCOSAL EOSINOPHILIC INFLAMMATION
GASTROESOPHAGEAL-REFLUX DISEASE
INHALED CORTICOSTEROIDS
Lower airway disease
Speech therapy
QUALITY-OF-LIFE
CHEST GUIDELINE
Immunology and Allergy
[SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology
Neuromodulators
VARIANT ASTHMA
Cough primary care
Science & Technology
CLINICAL-PRACTICE GUIDELINE
Reflux cough
REFRACTORY CHRONIC COUGH
Life Sciences & Biomedicine
[SDV.IMM.ALL] Life Sciences [q-bio]/Immunology/Allergology
Subjects
Details
- Language :
- English
- ISSN :
- 19394551
- Volume :
- 15
- Issue :
- 5
- Database :
- OpenAIRE
- Journal :
- World Allergy Organization journal
- Accession number :
- edsair.doi.dedup.....b6b5fcd04406773e9def0e0b9bd7cd9a